Lazard Asset Management
BNTX icon

Lazard Asset Management’s BioNTech BNTX Stock Holding History

Lazard Asset Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-7
Closed – – 2321
2024
Q4 		$0 Hold
7
– – ﹤0.01% 2296
2024
Q3 		$0 Sell
7
-7
-50% -$644 ﹤0.01% 2274
2024
Q2 		$0 Sell
14
-478
-97% -$43.7K ﹤0.01% 2233
2024
Q1 		$44K Sell
492
-89
-15% -$8.53K ﹤0.01% 1739
2023
Q4 		$59K Buy
581
+8
+1% +$806 ﹤0.01% 1845
2023
Q3 		$60K Buy
573
+11
+2% +$1.22K ﹤0.01% 1795
2023
Q2 		$59K Sell
562
-741
-57% -$83.3K ﹤0.01% 1776
2023
Q1 		$161K Sell
1,303
-3,041
-70% -$418K ﹤0.01% 1364
2022
Q4 		$651K Buy
4,344
+3,740
+619% +$576K ﹤0.01% 1073
2022
Q3 		$81K Buy
+604
New +$92.3K ﹤0.01% 1564
2021
Q4 		– Sell
-161
Closed -$43K – 2298
2021
Q3 		$43K Buy
+161
New +$51.2K ﹤0.01% 1745

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Lazard Asset Management's BNTX Position: Q1 2025 in Review

Lazard Asset Management sold out of BioNTech (BNTX) in Q1 2025, closing a stake of 7 shares.

Lazard Asset Management first reported a position in BNTX in Q3 2021 and held it in 11 quarters. The position peaked at $651K in Q4 2022. 280 funds tracked by Wall St. Rank hold BNTX as of Q1 2025.

  • Lazard Asset Management reported no remaining BioNTech position as of Q1 2025 after selling out during the quarter.
  • Lazard Asset Management sold 7 BioNTech shares in Q1 2025.
  • Lazard Asset Management first reported a position in BioNTech in Q3 2021 and held it in 11 quarters.
  • Lazard Asset Management's BioNTech position peaked at $651K in Q4 2022.
  • 280 funds tracked by Wall St. Rank held BioNTech as of Q1 2025.

Based on Lazard Asset Management's 13F filing for Q1 2025, filed 15 May 2025.